Atlas Trials

LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry)

Clinical trial NCT03053596 · COMPLETED

Trial details

NCT number
NCT03053596
Sponsor
Terumo Europe N.V.
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2016-11-01
Primary completion
2019-04-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.